Predictors of Severe Sepsis among Patients Hospitalized for Community-Acquired Pneumonia

Background Severe sepsis, may be present on hospital arrival in approximately one-third of patients with community-acquired pneumonia (CAP). Objective To determine the host characteristics and micro-organisms associated with severe sepsis in patients hospitalized with CAP. Results We performed a prospective multicenter cohort study in 13 Spanish hospital, on 4070 hospitalized CAP patients, 1529 of whom (37.6%) presented with severe sepsis. Severe sepsis CAP was independently associated with older age (>65 years), alcohol abuse (OR, 1.31; 95% CI, 1.07–1.61), chronic obstructive pulmonary disease (COPD) (OR, 1.75; 95% CI, 1.50–2.04) and renal disease (OR, 1.57; 95% CI, 1.21–2.03), whereas prior antibiotic treatment was a protective factor (OR, 0.62; 95% CI, 0.52–0.73). Bacteremia (OR, 1.37; 95% CI, 1.05–1.79), S pneumoniae (OR, 1.59; 95% CI, 1.31–1.95) and mixed microbial etiology (OR, 1.65; 95% CI, 1.10–2.49) were associated with severe sepsis CAP. Conclusions CAP patients with COPD, renal disease and alcohol abuse, as well as those with CAP due to S pneumonia or mixed micro-organisms are more likely to present to the hospital with severe sepsis.

[1]  E. Palomera,et al.  Relationship between the Use of Inhaled Steroids for Chronic Respiratory Diseases and Early Outcomes in Community-Acquired Pneumonia , 2013, PloS one.

[2]  A. Torres,et al.  Cytokine Activation Patterns and Biomarkers Are Influenced by Microorganisms in Community-Acquired Pneumonia , 2012, Chest.

[3]  D. Guidot,et al.  Alcohol abuse, the alveolar macrophage and pneumonia. , 2012, The American journal of the medical sciences.

[4]  A. Liapikou,et al.  Severity and outcomes of hospitalised community-acquired pneumonia in COPD patients , 2011, European Respiratory Journal.

[5]  A. Torres,et al.  Community-acquired polymicrobial pneumonia in the intensive care unit: aetiology and prognosis , 2011, Critical care.

[6]  J. Rello,et al.  Initial management of pneumonia and sepsis: factors associated with improved outcome , 2011, European Respiratory Journal.

[7]  C. Sessler,et al.  Alcohol-use disorders in the critically ill patient. , 2010, Chest.

[8]  D. Nathwani,et al.  Clinical and economic burden of community-acquired pneumonia among adults in Europe , 2010, Thorax.

[9]  J. Dorca,et al.  Pneumococcal pneumonia presenting with septic shock: host- and pathogen-related factors and outcomes , 2009, Thorax.

[10]  T. Welte,et al.  Global and Local Epidemiology of Community-Acquired Pneumonia: The Experience of the CAPNETZ Network , 2009, Seminars in respiratory and critical care medicine.

[11]  Jesús Blanco,et al.  Incidence, organ dysfunction and mortality in severe sepsis: a Spanish multicentre study , 2008, Critical care.

[12]  J. Rello.  Demographics, guidelines, and clinical experience in severe community-acquired pneumonia , 2008, Critical care.

[13]  A. Anzueto,et al.  A comparative study of community-acquired pneumonia patients admitted to the ward and the ICU. , 2008, Chest.

[14]  P. Zabel,et al.  Sepsis severity predicts outcome in community-acquired pneumococcal pneumonia , 2007, European Respiratory Journal.

[15]  A. Torres,et al.  Mixed community-acquired pneumonia in hospitalised patients , 2006, European Respiratory Journal.

[16]  M. Fine,et al.  Severe sepsis in community-acquired pneumonia: when does it happen, and do systemic inflammatory response syndrome criteria help predict course? , 2006, Chest.

[17]  P. Zabel,et al.  Pneumococcal septic shock is associated with the interleukin-10-1082 gene promoter polymorphism. , 2003, American journal of respiratory and critical care medicine.

[18]  W. Lim,et al.  Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study , 2003, Thorax.

[19]  Mitchell M. Levy,et al.  2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference , 2003, Intensive Care Medicine.

[20]  A. Trilla,et al.  Análisis de la relación coste-efectividad del tratamiento antibiótico empírico en pacientes con infecciones del tracto respiratorio inferior adquiridas en la comunidad , 2000 .

[21]  M. Niederman,et al.  Severe community-acquired pneumonia. Assessment of severity criteria. , 1998, American journal of respiratory and critical care medicine.

[22]  Inger,et al.  A prediction rule to identify low-risk patients with community-acquired pneumonia. , 1997, The New England journal of medicine.

[23]  D. Hosmer,et al.  Applied Logistic Regression , 1991 .

[24]  C. Codina,et al.  [Analysis of the cost-effectiveness relationship in the empirical treatment in patients with infections of the lower respiratory tract acquired in the community]. , 2000, Enfermedades infecciosas y microbiologia clinica.

[25]  A. Torres,et al.  Severe community-acquired pneumonia. Risk factors and follow-up epidemiology. , 1999, American journal of respiratory and critical care medicine.